219 related articles for article (PubMed ID: 11836932)
1. Pegnology: a review of PEG-ylated systems.
Bhadra D; Bhadra S; Jain P; Jain NK
Pharmazie; 2002 Jan; 57(1):5-29. PubMed ID: 11836932
[TBL] [Abstract][Full Text] [Related]
2. A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel.
Gou M; Li X; Dai M; Gong C; Wang X; Xie Y; Deng H; Chen L; Zhao X; Qian Z; Wei Y
Int J Pharm; 2008 Jul; 359(1-2):228-33. PubMed ID: 18448286
[TBL] [Abstract][Full Text] [Related]
3. Sustained release of growth factors.
Robinson SN; Talmadge JE
In Vivo; 2002; 16(6):535-40. PubMed ID: 12494898
[TBL] [Abstract][Full Text] [Related]
4. PEGylation, successful approach to drug delivery.
Veronese FM; Pasut G
Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
[TBL] [Abstract][Full Text] [Related]
5. PEGylated nanocarriers for systemic delivery.
Jain NK; Nahar M
Methods Mol Biol; 2010; 624():221-34. PubMed ID: 20217599
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a novel PEG-clay hybrid as a DDS material: dispersion stability and sustained release profiles.
Takahashi T; Yamada Y; Kataoka K; Nagasaki Y
J Control Release; 2005 Oct; 107(3):408-16. PubMed ID: 16171884
[TBL] [Abstract][Full Text] [Related]
7. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study.
Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ
J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072
[TBL] [Abstract][Full Text] [Related]
8. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
9. N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH.
Hu J; Sebald W
Int J Pharm; 2011 Jul; 413(1-2):140-6. PubMed ID: 21539904
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer PEG-enzymes: 30 years old, but still a current approach.
Pasut G; Sergi M; Veronese FM
Adv Drug Deliv Rev; 2008 Jan; 60(1):69-78. PubMed ID: 17869378
[TBL] [Abstract][Full Text] [Related]
11. Polypseudorotaxanes of pegylated insulin with cyclodextrins: application to sustained release system.
Higashi T; Hirayama F; Arima H; Uekama K
Bioorg Med Chem Lett; 2007 Apr; 17(7):1871-4. PubMed ID: 17291751
[TBL] [Abstract][Full Text] [Related]
12. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
13. Emerging PEGylated drugs.
Kang JS; Deluca PP; Lee KC
Expert Opin Emerg Drugs; 2009 Jun; 14(2):363-80. PubMed ID: 19453284
[TBL] [Abstract][Full Text] [Related]
14. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
[TBL] [Abstract][Full Text] [Related]
15. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
16. Polyethylene glycol modification: relevance of improved methodology to tumour targeting.
Francis GE; Delgado C; Fisher D; Malik F; Agrawal AK
J Drug Target; 1996; 3(5):321-40. PubMed ID: 8866652
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of degradable functional poly(ethylene glycol) analogs as versatile drug delivery carriers.
Wang N; Dong A; Tang H; Van Kirk EA; Johnson PA; Murdoch WJ; Radosz M; Shen Y
Macromol Biosci; 2007 Nov; 7(11):1187-98. PubMed ID: 17665412
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of polypseudorotaxanes of pegylated insulin with cyclodextrins as sustained release system.
Higashi T; Hirayama F; Misumi S; Arima H; Uekama K
Biomaterials; 2008 Oct; 29(28):3866-71. PubMed ID: 18620750
[TBL] [Abstract][Full Text] [Related]
19. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.
Awasthi VD; Garcia D; Klipper R; Goins BA; Phillips WT
J Pharmacol Exp Ther; 2004 Apr; 309(1):241-8. PubMed ID: 14718581
[TBL] [Abstract][Full Text] [Related]
20. Delivery of G3139 using releasable PEG-linkers: impact on pharmacokinetic profile and anti-tumor efficacy.
Zhao H; Peng P; Longley C; Zhang Y; Borowski V; Mehlig M; Reddy P; Xia J; Borchard G; Lipman J; Benimetskaya L; Stein CA
J Control Release; 2007 Jun; 119(2):143-52. PubMed ID: 17397960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
